Log In
Print
BCIQ
Print
Print this Print this
 

Aveed, Nebido, testosterone

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionLong-acting depot preparation of testosterone undecanoate
Molecular Target Not available
Mechanism of ActionHormone replacement therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat male hypogonadism; Treat testosterone deficiency (hypogonadism)
Regulatory Designation

Partner

Endo International plc


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$637.0M

$370.0M

$267.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today